These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35788259)

  • 21. Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease.
    Loh CH; Ohar JA
    Curr Opin Pulm Med; 2024 Mar; 30(2):174-178. PubMed ID: 38164804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons between In-Check DIAL® and PF810® in evaluation and training inspiratory capacity for using dry powder inhalers.
    Wu Y; Li L; Gong Y; Li X; Ye X; Zhang J
    BMC Pulm Med; 2024 Aug; 24(1):380. PubMed ID: 39095773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow.
    Huber B; Keller C; Jenkins M; Raza A; Aurivillius M
    Ther Adv Respir Dis; 2022; 16():17534666221107312. PubMed ID: 35815354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.
    Moon JY; Kim SH; Kim Y; Lee H; Rhee CK; Ra SW; Lee CY; Park JH; Park YB; Yoo KH
    Pulm Pharmacol Ther; 2024 Jun; 85():102298. PubMed ID: 38604404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
    Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD.
    Represas-Represas C; Aballe-Santos L; Fernández-García A; Priegue-Carrera A; López-Campos JL; González-Montaos A; Botana-Rial M; Fernández-Villar A
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33291438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.
    Leving MT; Bosnic-Anticevich S; van Cooten J; de Sousa JC; Cvetkovski B; Dekhuijzen R; Dijk L; Pardo MG; Gardev A; Gawlik R; van der Ham I; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Emerson-Stadler R; Kocks JWH
    NPJ Prim Care Respir Med; 2022 Dec; 32(1):59. PubMed ID: 36575175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
    Barnes CN; Mahler DA; Ohar JA; Lombardi DA; Crater GD
    Chest; 2020 Oct; 158(4):1413-1419. PubMed ID: 32343967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
    Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
    Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.
    Arawomo AO; Erhabor GE; Tanimowo MO; Awopeju OF; Adewole OO; Adeniyi BO; Afolabi BA; Ekundayo MW
    West Afr J Med; 2023 May; 40(5):553-561. PubMed ID: 37247343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler
    Malmberg LP; Pelkonen AS; Vartiainen V; Vahteristo M; Lähelmä S; Jõgi R
    J Thorac Dis; 2021 Feb; 13(2):621-631. PubMed ID: 33717535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Effectiveness of Written Dry Powder Inhaler Instructions and Health Literacy in Subjects Diagnosed With COPD.
    Alsomali HJ; Vines DL; Stein BD; Becker EA
    Respir Care; 2017 Feb; 62(2):172-178. PubMed ID: 28028187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
    Tiddens HA; Geller DE; Challoner P; Speirs RJ; Kesser KC; Overbeek SE; Humble D; Shrewsbury SB; Standaert TA
    J Aerosol Med; 2006; 19(4):456-65. PubMed ID: 17196074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
    W H Kocks J; Wouters H; Bosnic-Anticevich S; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; Dvortsin E; Garcia Pardo M; Gardev A; Gawlik R; van Geer-Postmus I; van der Ham I; Harbers M; de la Hoz A; Janse Y; Kerkhof M; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Leving MT
    NPJ Prim Care Respir Med; 2022 May; 32(1):18. PubMed ID: 35618739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Preliminary Bronchodilator Dose in Chronic Obstructive Pulmonary Disease Patients With Suboptimal Peak Inspiratory Flow.
    Hassan MI; Laz NI; Madney YM; Abdelrahim MEA; Harb HS
    Clin Ther; 2024 Dec; 46(12):e16-e24. PubMed ID: 39353752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.
    Melani AS; Bracci LS; Rossi M
    Clin Drug Investig; 2005; 25(8):543-9. PubMed ID: 17532698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study.
    Clark B; Wells BJ; Saha AK; Franchino-Elder J; Shaikh A; Donato BMK; Ohar JA
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1483-1494. PubMed ID: 35791340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.